カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の抗感染薬市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Anti-Infective Medications Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19147）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19147
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：105
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の抗感染薬市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

抗感染薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の抗感染薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

抗感染薬市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・抗ウイルス剤、抗菌剤、抗真菌剤

用途別セグメントは次のように区分されます。
・病院薬局、オンライン薬局、リテール薬局

世界の抗感染薬市場の主要な市場プレーヤーは以下のとおりです。
・Abbott、Astellas Pharma、Bayer、Bristol-Myers Squibb、Daiichi Sankyo、GlaxoSmithKline、Merck、Novartis、Pfizer、Roche

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、抗感染薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な抗感染薬メーカーの企業概要、2019年～2022年までの抗感染薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な抗感染薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別抗感染薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの抗感染薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での抗感染薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および抗感染薬の産業チェーンを掲載しています。
・第13、14、15章では、抗感染薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 抗感染薬の概要
- 種類別分析（2017年vs2021年vs2028年）：抗ウイルス剤、抗菌剤、抗真菌剤
- 用途別分析（2017年vs2021年vs2028年）：病院薬局、オンライン薬局、リテール薬局
- 世界の抗感染薬市場規模・予測
- 世界の抗感染薬生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Abbott、Astellas Pharma、Bayer、Bristol-Myers Squibb、Daiichi Sankyo、GlaxoSmithKline、Merck、Novartis、Pfizer、Roche
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：抗ウイルス剤、抗菌剤、抗真菌剤
・用途別分析2017年-2028年：病院薬局、オンライン薬局、リテール薬局
・抗感染薬の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・抗感染薬のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・抗感染薬のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・抗感染薬の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・抗感染薬の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Anti-Infective Medications market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Anti-Infective Medications market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital Pharmacies accounting for % of the Anti-Infective Medications global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Antivirals segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Anti-Infective Medications include Abbott, Astellas Pharma, Bayer, Bristol-Myers Squibb, and Daiichi Sankyo, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Anti-Infective Medications market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Antivirals
Antibacterials
Antifungals
Market segment by Application can be divided into
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
The key market players for global Anti-Infective Medications market are listed below:
Abbott
Astellas Pharma
Bayer
Bristol-Myers Squibb
Daiichi Sankyo
GlaxoSmithKline
Merck
Novartis
Pfizer
Roche
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anti-Infective Medications product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Anti-Infective Medications, with price, sales, revenue and global market share of Anti-Infective Medications from 2019 to 2022.
Chapter 3, the Anti-Infective Medications competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anti-Infective Medications breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Anti-Infective Medications market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Anti-Infective Medications.
Chapter 13, 14, and 15, to describe Anti-Infective Medications sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Anti-Infective Medications Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Anti-Infective Medications Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Antivirals
1.2.3 Antibacterials
1.2.4 Antifungals
1.3 Market Analysis by Application
1.3.1 Overview: Global Anti-Infective Medications Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Global Anti-Infective Medications Market Size & Forecast
1.4.1 Global Anti-Infective Medications Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Anti-Infective Medications Sales in Volume (2017-2028)
1.4.3 Global Anti-Infective Medications Price (2017-2028)
1.5 Global Anti-Infective Medications Production Capacity Analysis
1.5.1 Global Anti-Infective Medications Total Production Capacity (2017-2028)
1.5.2 Global Anti-Infective Medications Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Anti-Infective Medications Market Drivers
1.6.2 Anti-Infective Medications Market Restraints
1.6.3 Anti-Infective Medications Trends Analysis
2 Manufacturers Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Anti-Infective Medications Product and Services
2.1.4 Abbott Anti-Infective Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Astellas Pharma
2.2.1 Astellas Pharma Details
2.2.2 Astellas Pharma Major Business
2.2.3 Astellas Pharma Anti-Infective Medications Product and Services
2.2.4 Astellas Pharma Anti-Infective Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer Anti-Infective Medications Product and Services
2.3.4 Bayer Anti-Infective Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Bristol-Myers Squibb
2.4.1 Bristol-Myers Squibb Details
2.4.2 Bristol-Myers Squibb Major Business
2.4.3 Bristol-Myers Squibb Anti-Infective Medications Product and Services
2.4.4 Bristol-Myers Squibb Anti-Infective Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Daiichi Sankyo
2.5.1 Daiichi Sankyo Details
2.5.2 Daiichi Sankyo Major Business
2.5.3 Daiichi Sankyo Anti-Infective Medications Product and Services
2.5.4 Daiichi Sankyo Anti-Infective Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 GlaxoSmithKline
2.6.1 GlaxoSmithKline Details
2.6.2 GlaxoSmithKline Major Business
2.6.3 GlaxoSmithKline Anti-Infective Medications Product and Services
2.6.4 GlaxoSmithKline Anti-Infective Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business
2.7.3 Merck Anti-Infective Medications Product and Services
2.7.4 Merck Anti-Infective Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Novartis
2.8.1 Novartis Details
2.8.2 Novartis Major Business
2.8.3 Novartis Anti-Infective Medications Product and Services
2.8.4 Novartis Anti-Infective Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Pfizer
2.9.1 Pfizer Details
2.9.2 Pfizer Major Business
2.9.3 Pfizer Anti-Infective Medications Product and Services
2.9.4 Pfizer Anti-Infective Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Roche
2.10.1 Roche Details
2.10.2 Roche Major Business
2.10.3 Roche Anti-Infective Medications Product and Services
2.10.4 Roche Anti-Infective Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Anti-Infective Medications Breakdown Data by Manufacturer
3.1 Global Anti-Infective Medications Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Anti-Infective Medications Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Anti-Infective Medications
3.4 Market Concentration Rate
3.4.1 Top 3 Anti-Infective Medications Manufacturer Market Share in 2021
3.4.2 Top 6 Anti-Infective Medications Manufacturer Market Share in 2021
3.5 Global Anti-Infective Medications Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Anti-Infective Medications Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Anti-Infective Medications Market Size by Region
4.1.1 Global Anti-Infective Medications Sales in Volume by Region (2017-2028)
4.1.2 Global Anti-Infective Medications Revenue by Region (2017-2028)
4.2 North America Anti-Infective Medications Revenue (2017-2028)
4.3 Europe Anti-Infective Medications Revenue (2017-2028)
4.4 Asia-Pacific Anti-Infective Medications Revenue (2017-2028)
4.5 South America Anti-Infective Medications Revenue (2017-2028)
4.6 Middle East and Africa Anti-Infective Medications Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Anti-Infective Medications Sales in Volume by Type (2017-2028)
5.2 Global Anti-Infective Medications Revenue by Type (2017-2028)
5.3 Global Anti-Infective Medications Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Anti-Infective Medications Sales in Volume by Application (2017-2028)
6.2 Global Anti-Infective Medications Revenue by Application (2017-2028)
6.3 Global Anti-Infective Medications Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Anti-Infective Medications Sales by Type (2017-2028)
7.2 North America Anti-Infective Medications Sales by Application (2017-2028)
7.3 North America Anti-Infective Medications Market Size by Country
7.3.1 North America Anti-Infective Medications Sales in Volume by Country (2017-2028)
7.3.2 North America Anti-Infective Medications Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Anti-Infective Medications Sales by Type (2017-2028)
8.2 Europe Anti-Infective Medications Sales by Application (2017-2028)
8.3 Europe Anti-Infective Medications Market Size by Country
8.3.1 Europe Anti-Infective Medications Sales in Volume by Country (2017-2028)
8.3.2 Europe Anti-Infective Medications Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Anti-Infective Medications Sales by Type (2017-2028)
9.2 Asia-Pacific Anti-Infective Medications Sales by Application (2017-2028)
9.3 Asia-Pacific Anti-Infective Medications Market Size by Region
9.3.1 Asia-Pacific Anti-Infective Medications Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Anti-Infective Medications Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Anti-Infective Medications Sales by Type (2017-2028)
10.2 South America Anti-Infective Medications Sales by Application (2017-2028)
10.3 South America Anti-Infective Medications Market Size by Country
10.3.1 South America Anti-Infective Medications Sales in Volume by Country (2017-2028)
10.3.2 South America Anti-Infective Medications Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Anti-Infective Medications Sales by Type (2017-2028)
11.2 Middle East & Africa Anti-Infective Medications Sales by Application (2017-2028)
11.3 Middle East & Africa Anti-Infective Medications Market Size by Country
11.3.1 Middle East & Africa Anti-Infective Medications Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Anti-Infective Medications Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Anti-Infective Medications and Key Manufacturers
12.2 Manufacturing Costs Percentage of Anti-Infective Medications
12.3 Anti-Infective Medications Production Process
12.4 Anti-Infective Medications Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Anti-Infective Medications Typical Distributors
13.3 Anti-Infective Medications Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Anti-Infective Medications Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Anti-Infective Medications Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Abbott Basic Information, Manufacturing Base and Competitors
Table 4. Abbott Major Business
Table 5. Abbott Anti-Infective Medications Product and Services
Table 6. Abbott Anti-Infective Medications Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 8. Astellas Pharma Major Business
Table 9. Astellas Pharma Anti-Infective Medications Product and Services
Table 10. Astellas Pharma Anti-Infective Medications Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Bayer Basic Information, Manufacturing Base and Competitors
Table 12. Bayer Major Business
Table 13. Bayer Anti-Infective Medications Product and Services
Table 14. Bayer Anti-Infective Medications Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 16. Bristol-Myers Squibb Major Business
Table 17. Bristol-Myers Squibb Anti-Infective Medications Product and Services
Table 18. Bristol-Myers Squibb Anti-Infective Medications Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 20. Daiichi Sankyo Major Business
Table 21. Daiichi Sankyo Anti-Infective Medications Product and Services
Table 22. Daiichi Sankyo Anti-Infective Medications Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 24. GlaxoSmithKline Major Business
Table 25. GlaxoSmithKline Anti-Infective Medications Product and Services
Table 26. GlaxoSmithKline Anti-Infective Medications Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Merck Basic Information, Manufacturing Base and Competitors
Table 28. Merck Major Business
Table 29. Merck Anti-Infective Medications Product and Services
Table 30. Merck Anti-Infective Medications Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Novartis Basic Information, Manufacturing Base and Competitors
Table 32. Novartis Major Business
Table 33. Novartis Anti-Infective Medications Product and Services
Table 34. Novartis Anti-Infective Medications Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Pfizer Basic Information, Manufacturing Base and Competitors
Table 36. Pfizer Major Business
Table 37. Pfizer Anti-Infective Medications Product and Services
Table 38. Pfizer Anti-Infective Medications Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Roche Basic Information, Manufacturing Base and Competitors
Table 40. Roche Major Business
Table 41. Roche Anti-Infective Medications Product and Services
Table 42. Roche Anti-Infective Medications Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Global Anti-Infective Medications Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 44. Global Anti-Infective Medications Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 45. Market Position of Manufacturers in Anti-Infective Medications, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 46. Global Anti-Infective Medications Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Anti-Infective Medications Production Site of Key Manufacturer
Table 48. Anti-Infective Medications New Entrant and Capacity Expansion Plans
Table 49. Anti-Infective Medications Mergers & Acquisitions in the Past Five Years
Table 50. Global Anti-Infective Medications Sales by Region (2017-2022) & (K Units)
Table 51. Global Anti-Infective Medications Sales by Region (2023-2028) & (K Units)
Table 52. Global Anti-Infective Medications Revenue by Region (2017-2022) & (USD Million)
Table 53. Global Anti-Infective Medications Revenue by Region (2023-2028) & (USD Million)
Table 54. Global Anti-Infective Medications Sales by Type (2017-2022) & (K Units)
Table 55. Global Anti-Infective Medications Sales by Type (2023-2028) & (K Units)
Table 56. Global Anti-Infective Medications Revenue by Type (2017-2022) & (USD Million)
Table 57. Global Anti-Infective Medications Revenue by Type (2023-2028) & (USD Million)
Table 58. Global Anti-Infective Medications Price by Type (2017-2022) & (USD/Unit)
Table 59. Global Anti-Infective Medications Price by Type (2023-2028) & (USD/Unit)
Table 60. Global Anti-Infective Medications Sales by Application (2017-2022) & (K Units)
Table 61. Global Anti-Infective Medications Sales by Application (2023-2028) & (K Units)
Table 62. Global Anti-Infective Medications Revenue by Application (2017-2022) & (USD Million)
Table 63. Global Anti-Infective Medications Revenue by Application (2023-2028) & (USD Million)
Table 64. Global Anti-Infective Medications Price by Application (2017-2022) & (USD/Unit)
Table 65. Global Anti-Infective Medications Price by Application (2023-2028) & (USD/Unit)
Table 66. North America Anti-Infective Medications Sales by Country (2017-2022) & (K Units)
Table 67. North America Anti-Infective Medications Sales by Country (2023-2028) & (K Units)
Table 68. North America Anti-Infective Medications Revenue by Country (2017-2022) & (USD Million)
Table 69. North America Anti-Infective Medications Revenue by Country (2023-2028) & (USD Million)
Table 70. North America Anti-Infective Medications Sales by Type (2017-2022) & (K Units)
Table 71. North America Anti-Infective Medications Sales by Type (2023-2028) & (K Units)
Table 72. North America Anti-Infective Medications Sales by Application (2017-2022) & (K Units)
Table 73. North America Anti-Infective Medications Sales by Application (2023-2028) & (K Units)
Table 74. Europe Anti-Infective Medications Sales by Country (2017-2022) & (K Units)
Table 75. Europe Anti-Infective Medications Sales by Country (2023-2028) & (K Units)
Table 76. Europe Anti-Infective Medications Revenue by Country (2017-2022) & (USD Million)
Table 77. Europe Anti-Infective Medications Revenue by Country (2023-2028) & (USD Million)
Table 78. Europe Anti-Infective Medications Sales by Type (2017-2022) & (K Units)
Table 79. Europe Anti-Infective Medications Sales by Type (2023-2028) & (K Units)
Table 80. Europe Anti-Infective Medications Sales by Application (2017-2022) & (K Units)
Table 81. Europe Anti-Infective Medications Sales by Application (2023-2028) & (K Units)
Table 82. Asia-Pacific Anti-Infective Medications Sales by Region (2017-2022) & (K Units)
Table 83. Asia-Pacific Anti-Infective Medications Sales by Region (2023-2028) & (K Units)
Table 84. Asia-Pacific Anti-Infective Medications Revenue by Region (2017-2022) & (USD Million)
Table 85. Asia-Pacific Anti-Infective Medications Revenue by Region (2023-2028) & (USD Million)
Table 86. Asia-Pacific Anti-Infective Medications Sales by Type (2017-2022) & (K Units)
Table 87. Asia-Pacific Anti-Infective Medications Sales by Type (2023-2028) & (K Units)
Table 88. Asia-Pacific Anti-Infective Medications Sales by Application (2017-2022) & (K Units)
Table 89. Asia-Pacific Anti-Infective Medications Sales by Application (2023-2028) & (K Units)
Table 90. South America Anti-Infective Medications Sales by Country (2017-2022) & (K Units)
Table 91. South America Anti-Infective Medications Sales by Country (2023-2028) & (K Units)
Table 92. South America Anti-Infective Medications Revenue by Country (2017-2022) & (USD Million)
Table 93. South America Anti-Infective Medications Revenue by Country (2023-2028) & (USD Million)
Table 94. South America Anti-Infective Medications Sales by Type (2017-2022) & (K Units)
Table 95. South America Anti-Infective Medications Sales by Type (2023-2028) & (K Units)
Table 96. South America Anti-Infective Medications Sales by Application (2017-2022) & (K Units)
Table 97. South America Anti-Infective Medications Sales by Application (2023-2028) & (K Units)
Table 98. Middle East & Africa Anti-Infective Medications Sales by Region (2017-2022) & (K Units)
Table 99. Middle East & Africa Anti-Infective Medications Sales by Region (2023-2028) & (K Units)
Table 100. Middle East & Africa Anti-Infective Medications Revenue by Region (2017-2022) & (USD Million)
Table 101. Middle East & Africa Anti-Infective Medications Revenue by Region (2023-2028) & (USD Million)
Table 102. Middle East & Africa Anti-Infective Medications Sales by Type (2017-2022) & (K Units)
Table 103. Middle East & Africa Anti-Infective Medications Sales by Type (2023-2028) & (K Units)
Table 104. Middle East & Africa Anti-Infective Medications Sales by Application (2017-2022) & (K Units)
Table 105. Middle East & Africa Anti-Infective Medications Sales by Application (2023-2028) & (K Units)
Table 106. Anti-Infective Medications Raw Material
Table 107. Key Manufacturers of Anti-Infective Medications Raw Materials
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Anti-Infective Medications Typical Distributors
Table 111. Anti-Infective Medications Typical Customers
List of Figures
Figure 1. Anti-Infective Medications Picture
Figure 2. Global Anti-Infective Medications Revenue Market Share by Type in 2021
Figure 3. Antivirals
Figure 4. Antibacterials
Figure 5. Antifungals
Figure 6. Global Anti-Infective Medications Revenue Market Share by Application in 2021
Figure 7. Hospital Pharmacies
Figure 8. Online Pharmacies
Figure 9. Retail Pharmacies
Figure 10. Global Anti-Infective Medications Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 11. Global Anti-Infective Medications Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Anti-Infective Medications Sales (2017-2028) & (K Units)
Figure 13. Global Anti-Infective Medications Price (2017-2028) & (USD/Unit)
Figure 14. Global Anti-Infective Medications Production Capacity (2017-2028) & (K Units)
Figure 15. Global Anti-Infective Medications Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Anti-Infective Medications Market Drivers
Figure 17. Anti-Infective Medications Market Restraints
Figure 18. Anti-Infective Medications Market Trends
Figure 19. Global Anti-Infective Medications Sales Market Share by Manufacturer in 2021
Figure 20. Global Anti-Infective Medications Revenue Market Share by Manufacturer in 2021
Figure 21. Anti-Infective Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Anti-Infective Medications Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Anti-Infective Medications Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Anti-Infective Medications Sales Market Share by Region (2017-2028)
Figure 25. Global Anti-Infective Medications Revenue Market Share by Region (2017-2028)
Figure 26. North America Anti-Infective Medications Revenue (2017-2028) & (USD Million)
Figure 27. Europe Anti-Infective Medications Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Anti-Infective Medications Revenue (2017-2028) & (USD Million)
Figure 29. South America Anti-Infective Medications Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Anti-Infective Medications Revenue (2017-2028) & (USD Million)
Figure 31. Global Anti-Infective Medications Sales Market Share by Type (2017-2028)
Figure 32. Global Anti-Infective Medications Revenue Market Share by Type (2017-2028)
Figure 33. Global Anti-Infective Medications Price by Type (2017-2028) & (USD/Unit)
Figure 34. Global Anti-Infective Medications Sales Market Share by Application (2017-2028)
Figure 35. Global Anti-Infective Medications Revenue Market Share by Application (2017-2028)
Figure 36. Global Anti-Infective Medications Price by Application (2017-2028) & (USD/Unit)
Figure 37. North America Anti-Infective Medications Sales Market Share by Type (2017-2028)
Figure 38. North America Anti-Infective Medications Sales Market Share by Application (2017-2028)
Figure 39. North America Anti-Infective Medications Sales Market Share by Country (2017-2028)
Figure 40. North America Anti-Infective Medications Revenue Market Share by Country (2017-2028)
Figure 41. United States Anti-Infective Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Anti-Infective Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Anti-Infective Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Anti-Infective Medications Sales Market Share by Type (2017-2028)
Figure 45. Europe Anti-Infective Medications Sales Market Share by Application (2017-2028)
Figure 46. Europe Anti-Infective Medications Sales Market Share by Country (2017-2028)
Figure 47. Europe Anti-Infective Medications Revenue Market Share by Country (2017-2028)
Figure 48. Germany Anti-Infective Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Anti-Infective Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Anti-Infective Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Anti-Infective Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Anti-Infective Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Anti-Infective Medications Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Anti-Infective Medications Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Anti-Infective Medications Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Anti-Infective Medications Revenue Market Share by Region (2017-2028)
Figure 57. China Anti-Infective Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Anti-Infective Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Anti-Infective Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Anti-Infective Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Anti-Infective Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Anti-Infective Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Anti-Infective Medications Sales Market Share by Type (2017-2028)
Figure 64. South America Anti-Infective Medications Sales Market Share by Application (2017-2028)
Figure 65. South America Anti-Infective Medications Sales Market Share by Country (2017-2028)
Figure 66. South America Anti-Infective Medications Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Anti-Infective Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Anti-Infective Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Anti-Infective Medications Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Anti-Infective Medications Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Anti-Infective Medications Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Anti-Infective Medications Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Anti-Infective Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Anti-Infective Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Anti-Infective Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Anti-Infective Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Anti-Infective Medications in 2021
Figure 78. Manufacturing Process Analysis of Anti-Infective Medications
Figure 79. Anti-Infective Medications Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の畜産用抗感染症薬市場2022年：市場規模予測（～2028年）
  • 抗感染症薬のグローバル市場展望 2023年-2029年：OTC、Rx治療薬
  • 世界のOTC鎮痛剤市場2022年：市場規模予測（～2028年）
  • 世界の関節炎治療用処方薬市場2022年：市場規模予測（～2028年）
  • 世界の新型コロナウイルス感染症用経口抗ウイルス薬市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19147 )"世界の抗感染薬市場2022年：市場規模予測（～2028年）" (英文：Global Anti-Infective Medications Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。